Company Filing History:
3 out of 8,373 
1 out of 664 
1 out of 1,209 
Years Active: 2021-2022
Title: The Innovative Contributions of Amy E. Keating
Introduction
Amy E. Keating is a prominent inventor based in Arlington, MA, known for her significant contributions to the field of cancer research. With a total of three patents to her name, she has made strides in developing peptides that target specific proteins involved in cancer progression.
Latest Patents
One of her latest patents focuses on "Peptides selective for Bcl-2 family proteins." This invention provides peptides that selectively target combinations of Mcl-1, Bfl-1, and Bcl-xL. The patent also includes compositions containing these polypeptides and outlines methods for using them in cancer treatment by administering one of the polypeptides to a subject. Another notable patent is for "Selective Bfl-1 peptides," which describes compounds comprising peptides that bind to Bfl-1. Similar to her previous work, this patent includes compositions and methods for using these peptides in cancer treatment.
Career Highlights
Throughout her career, Amy has worked with prestigious institutions such as the Massachusetts Institute of Technology and Dartmouth College. Her research has focused on the development of innovative therapeutic strategies to combat cancer, showcasing her dedication to advancing medical science.
Collaborations
Amy has collaborated with notable colleagues, including Justin Michael Jenson and Vincent Xue, further enhancing her research and contributions to the field.
Conclusion
Amy E. Keating's work exemplifies the impact of innovative research in the fight against cancer. Her patents and collaborations reflect her commitment to improving treatment options and advancing scientific knowledge.